Cancer Risk Among Participants in the Women???s Interagency HIV Study
- 1 August 2004
- journal article
- research article
- Published by Wolters Kluwer Health in JAIDS Journal of Acquired Immune Deficiency Syndromes
- Vol. 36 (4) , 978-985
- https://doi.org/10.1097/00126334-200408010-00013
Abstract
The HIV epidemic has been associated with an increased incidence of specific cancers. However, less is known about cancers occurring in HIV-infected women than men. To determine the risk of cancer among HIV-infected and at-risk HIV-uninfected women, cancer incidence data from the Women’s Interagency HIV Study (WIHS) were compared with data from the population-based United States Surveillance, Epidemiology, and End Results (SEER) registry. Age- and race-adjusted standardized incidence ratios (SIRs) were computed and exact statistical tests were used to measure significance. Among the 1950 women participants (1554 HIV infected, 391 HIV uninfected, and 5 HIV seroconverters), 48 cancers were diagnosed during study follow-up. Among HIV-infected women, significantly (P P In the HAART era, the higher rates of cancer among HIV-infected women, coupled with increased life expectancy, should lead to more intensive cancer screening and prevention efforts in this population.Keywords
This publication has 19 references indexed in Scilit:
- Low incidence of invasive cervical cancer among HIV-infected US women in a prevention programAIDS, 2004
- AIDS and cancer in the era of highly active antiretroviral therapy (HAART)European Journal Of Cancer, 2001
- Decreasing rates of Kaposi's sarcoma and non-Hodgkin's lymphoma in the era of potent combination anti-retroviral therapyAIDS, 2001
- Highly Active Antiretroviral Therapy and Incidence of Cancer in Human Immunodeficiency Virus-Infected AdultsJNCI Journal of the National Cancer Institute, 2000
- Epidemiology of Human Immunodeficiency Virus–Associated Opportunistic Infections in the United States in the Era of Highly Active Antiretroviral TherapyClinical Infectious Diseases, 2000
- Natural history of HIV infection in the_era of combination antiretroviral therapyAIDS, 1999
- PHASE II TRIAL OF INFUSIONAL CYCLOPHOSPHAMIDE, DOXORUBICIN, & ETOPOSIDE (CDE) IN HIV-ASSOCIATED NON-HODGKIN'S LYMPHOMA (NHL): AN EASTERN COOPERATIVE ONCOLOGY GROUP (ECOG) TRIAL (E1494).JAIDS Journal of Acquired Immune Deficiency Syndromes, 1999
- The Womenʼs Interagency HIV StudyEpidemiology, 1998
- Identification of Herpesvirus-Like DNA Sequences in AIDS-Sssociated Kaposi's SarcomaScience, 1994
- VIRUS PARTICLES IN CULTURED LYMPHOBLASTS FROM BURKITT'S LYMPHOMAThe Lancet, 1964